Zimbabwe has declined a substantial US health deal valued at $367m (272 million pounds) spanning five years due to Washington's insistence on sensitive biological samples.
This rejection came to light following a government memo from December was leaked, which showed President Emmerson Mnangagwa believed the agreement was "skewed".
A government spokesperson has since clarified that the United States was demanding access to health data for research and profit but was unwilling to guarantee the resulting advantages from future medical innovations.
"We will now turn to the difficult and regrettable task of winding down our support in Zimbabwe," remarked US ambassador to Zimbabwe Pamela Tremont in a statement.
The US Embassy indicated the United States had provided over $1.9bn for health programmes to Zimbabwe during the past twenty years.
A medical body in Zimbabwe has urged more negotiations to find a deal agreeable to all parties so the nation's vital HIV treatment initiative can continue.
Broader Implications
This development comes after a similar situation in neighbouring Kenya, where a high court suspended a similar health funding agreement after legal challenges were raised about the safety of Kenyans' medical information.
Since returning to the presidency recently, US President Donald Trump has reduced overseas assistance and closed the US Agency for International Development (USAID).
The agency had administered assistance for the American government, but Trump stated its expenditure was "inefficient" and his government was pursuing direct bilateral deals to enhance transparency and responsibility.
As per statements, Sixteen African countries have to date agreed to similar agreements, constituting more than $18.3bn of fresh investment.
Details of the Rejected Agreement
This assistance for Zimbabwe would have supported "tackling HIV/Aids, tuberculosis, malaria, maternal and child health, and preparing for epidemics".
"We are confident this cooperation might have yielded significant benefits for Zimbabwean communities, especially the 1.2 million men, women and children currently receiving antiretroviral therapy through American-funded initiatives," Tremont commented.
However, government spokesperson Nick Mangwana maintained the arrangement was "unequal".
"The proposal required Zimbabwe to surrender its genetic material and health information over an extended period, without any corresponding assurance of benefiting from any medical innovations – such as new medicines or tests – that might be developed from that provided information," his statement read.
"Effectively, our nation would provide the raw materials for medical research with no certainty that the end products would be available to our people if a future health crisis arise."
National Interest and International Frameworks
Mangwana further noted that the American exit from the World Health Organization (WHO) and its pursuit of one-on-one deals were upending frameworks already established through the international organization.
The spokesperson cited its Pathogen Access and Benefit Sharing system created to deal with future global health emergencies.
"This framework is designed to ensure that when a country contributes its data, the benefits – such as vaccines and treatments – are shared equitably, not commercialised solely by those with the resources to create them."
These objections over the US deal "should not be misconstrued as hostility towards the US," he added.
"We are open to continued dialogue with our US partners on how future co-operation could be designed in a manner that honours the independence and interests of both nations."
Medical Community Response
The Zimbabwe College of Public Health Physicians (ZCPHP) expressed it recognised the official position, but recommended that negotiations need to persist considering a large portion of the nation's HIV programmes relied on foreign aid.
"In cases where specific concerns arise, such as those involving information security or implementation frameworks, these can frequently be resolved through technical clarification and negotiated safeguards," the group said.
This impasse highlights the complex tensions between receiving vital foreign assistance and protecting national sovereignty in an increasingly interconnected world.